If you are interested in knowing the Aster DM Healthcare Share Price Target from 2025 to 2050, you are at the right place. In this blog, we will provide a detailed analysis of Aster DM Healthcare’s future share price targets based on its business performance, financials, and future growth plans.
Aster DM Healthcare is a leading healthcare company that operates hospitals, clinics, and pharmacies in India and Gulf (GCC) countries. Over the past few years, the company has shown consistent growth and is now shifting more focus toward expanding its presence in the Indian healthcare market. This blog will give you valuable insights into the company’s fundamentals, long-term potential, and whether it can be a strong stock for long-term investment.
About Aster DM Healthcare Limited
Aster DM Healthcare Limited is a multinational healthcare company founded by Dr. Azad Moopen in 1987. The journey began with a single clinic in Dubai, which laid the foundation for what would become the Aster Group.
Today, the company operates not just in India but also in countries like the UAE, Saudi Arabia, Oman, Qatar, Bahrain, and Kuwait. Aster DM provides a wide range of healthcare services including hospitals, clinics, pharmacies, diagnostic centres, and labs.
Around 94% of the company’s revenue comes from its hospitals and clinics, while the remaining 6% is generated from its labs and pharmacies. The company has a strong focus on specialized treatments—especially in critical areas like cardiac care, neurology, liver, and oncology. In India, Aster DM’s strategic goal is to become one of the top 3 healthcare providers in the country.
Aster DM Healthcare Financial Highlights
| Market Cap | ₹24,951 Cr. |
| Stock PE | 86.2 |
| Industry PE | 53.7 |
| ROCE | 4.48% |
| ROE | 3.13% |
| EPS | ₹106 |
| Debt to Equity | 0.56 |
| Debt | ₹1,940 Cr. |
| Dividend Yield | 0.80% |
| Book Value | ₹68.8 |
| Face Value | ₹10.0 |
| Sales | ₹3,699 Cr. |
| 5 Year Sales Growth | -57.24% |
| Profit Before Tax | ₹268 Cr. |
| 5 Year Profit Growth | -18.7% |
Pros:
- The company does not have a lot of debt. Its debt-to-equity ratio is 0.56, with total debt of just ₹1,940 Cr, which is manageable.
- The EPS is ₹106, meaning each share is earning well. This is a positive sign for investors.
- Although the company’s sales have gone down, it is still making a profit before paying tax, which shows it is not in losses.
Cons:
- The company’s PE ratio is currently 86.2, which is very high. The stock looks expensive compared to its earnings.
- Both ROE and ROCE are quite low, which means the company is giving poor returns on its investments.
- In the last 5 years, the company’s sales dropped by 57% and profit dropped by 19%, which is a major negative point.
Overall, Aster DM Healthcare is a neutral company in terms of fundamentals. This means its financial health is neither very weak nor very strong. Interestingly, the company saw its highest profit and sales in 2022, but after that, both sales and profit growth have turned negative.
Aster DM Healthcare Share Price History
| Date | Price | Open | High | Low | Vol. | Change % |
|---|---|---|---|---|---|---|
| Apr 01, 2025 | 499.50 | 479.45 | 509.90 | 450.00 | 11.12M | +3.31% |
| Mar 01, 2025 | 483.50 | 403.00 | 504.00 | 387.10 | 40.75M | +19.99% |
| Feb 01, 2025 | 402.95 | 469.55 | 496.60 | 392.00 | 16.69M | -18.02% |
| Jan 01, 2025 | 491.55 | 513.95 | 534.80 | 466.95 | 16.57M | -4.36% |
| Dec 01, 2024 | 513.95 | 507.50 | 524.65 | 472.30 | 30.92M | +2.80% |
| Nov 01, 2024 | 499.95 | 446.25 | 510.00 | 426.00 | 30.15M | +12.45% |
| Oct 01, 2024 | 444.60 | 415.00 | 464.00 | 396.20 | 42.29M | +7.11% |
| Sep 01, 2024 | 415.10 | 408.00 | 439.00 | 398.75 | 19.06M | +2.07% |
| Aug 01, 2024 | 406.70 | 362.50 | 417.50 | 354.90 | 48.76M | +17.19% |
| Jul 01, 2024 | 347.05 | 347.90 | 353.95 | 315.50 | 27.32M | +0.12% |
| Jun 01, 2024 | 346.65 | 372.90 | 387.70 | 311.10 | 52.06M | -4.75% |
| May 01, 2024 | 363.95 | 348.20 | 383.00 | 338.00 | 29.30M | +4.54% |
| Apr 01, 2024 | 348.15 | 315.41 | 429.74 | 310.56 | 91.22M | +10.45% |
In the last 5 years, Aster DM Healthcare has given a return of 377.84%. Although the company’s fundamentals are not very strong, the stock has still delivered impressive returns. The share price history clearly shows that the stock has been in a strong uptrend and is moving upward at a rapid pace.
Aster DM Healthcare Share Price Target 2025
According to technical analysis, Aster DM Healthcare share price target for 2025 is expected to range between a minimum of ₹385 to a maximum of ₹592. On 4th March 2025, the stock witnessed a slight correction and touched the level of ₹395, showing temporary weakness in the trend. However, the stock has now started showing signs of a fresh uptrend, indicating renewed buying interest and positive momentum building up once again.
| Month | Aster DM Target Price 2025 |
|---|---|
| January 2025 | ₹535.00 |
| February 2025 | ₹486.73 |
| March 2025 | ₹498.45 |
| April 2025 | ₹531.18 |
| May 2025 | ₹549.91 |
| June 2025 | ₹573.64 |
| July 2025 | ₹561.36 |
| August 2025 | ₹554.09 |
| September 2025 | ₹566.82 |
| October 2025 | ₹574.55 |
| November 2025 | ₹581.27 |
| December 2025 | ₹592.00 |
Read Also: Genus Power Share Price Target 2025, 2030, 2035, 2040 to 2050
Aster DM Healthcare Share Price Target 2026
In 2026, Aster DM Healthcare share price target can range from a minimum of ₹491 to a maximum of ₹683. Aster is one of the top healthcare companies in India. It holds the 2nd largest hospital network in South India, has the highest number of beds in Kerala, ranks 2nd in Andhra Pradesh, and 3rd in Karnataka. In the coming time, Aster is planning further expansion, which could bring strong growth in its share price.
| Month | Aster DM Target Price 2026 |
|---|---|
| January 2025 | ₹586.00 |
| February 2025 | ₹557.45 |
| March 2025 | ₹543.91 |
| April 2025 | ₹535.36 |
| May 2025 | ₹556.82 |
| June 2025 | ₹573.27 |
| July 2025 | ₹589.73 |
| August 2025 | ₹606.18 |
| September 2025 | ₹622.64 |
| October 2025 | ₹639.09 |
| November 2025 | ₹655.55 |
| December 2025 | ₹683.00 |
Aster DM Healthcare Share Price Target 2030
By 2030, Aster DM Healthcare share price target can go from a minimum of ₹883 to a maximum of ₹1,083. After demerging its GCC Middle East business, the company has made a strong plan to grow in India. Now, Aster is focusing on expanding into Tier 2 and Tier 3 cities by opening new hospitals, clinics, and diagnostic labs. This strategic move can help the company scale its presence in India, which may lead to strong upside potential in the share price.
| Month | Aster DM Target Price 2030 |
|---|---|
| January 2025 | ₹883.00 |
| February 2025 | ₹900.27 |
| March 2025 | ₹917.55 |
| April 2025 | ₹934.82 |
| May 2025 | ₹952.09 |
| June 2025 | ₹969.36 |
| July 2025 | ₹986.64 |
| August 2025 | ₹1,003.91 |
| September 2025 | ₹1,021.18 |
| October 2025 | ₹1,038.45 |
| November 2025 | ₹1,055.73 |
| December 2025 | ₹1,083.00 |
Aster DM Healthcare Share Price Target 2035
Aster DM Healthcare share price target by 2035 can range from a minimum of ₹1,642 to a maximum of ₹1,983. The company has started investing in digital health platforms, telemedicine, and AI-based diagnostic tools to enhance patient experience and increase its overall reach.
| Month | Aster DM Target Price 2035 |
|---|---|
| January 2025 | ₹1,642.00 |
| February 2025 | ₹1,671.36 |
| March 2025 | ₹1,700.73 |
| April 2025 | ₹1,730.09 |
| May 2025 | ₹1,759.45 |
| June 2025 | ₹1,788.82 |
| July 2025 | ₹1,818.18 |
| August 2025 | ₹1,847.55 |
| September 2025 | ₹1,876.91 |
| October 2025 | ₹1,906.27 |
| November 2025 | ₹1,935.64 |
| December 2025 | ₹1,983.00 |
Aster DM Healthcare Share Price Target 2040
By 2040, Aster DM Healthcare share price target can go from a minimum of ₹2,717 to a maximum of ₹3,178. The company is highly focused on its core business and is also working on improving the quality of care. Along with that, Aster is hiring top medical talent to ensure advanced treatment facilities are available across all its locations.
| Month | Aster DM Target Price 2040 |
|---|---|
| January 2025 | ₹2,717.00 |
| February 2025 | ₹2,755.64 |
| March 2025 | ₹2,794.27 |
| April 2025 | ₹2,832.91 |
| May 2025 | ₹2,871.55 |
| June 2025 | ₹2,910.18 |
| July 2025 | ₹2,948.82 |
| August 2025 | ₹2,987.45 |
| September 2025 | ₹3,026.09 |
| October 2025 | ₹3,064.73 |
| November 2025 | ₹3,103.36 |
| December 2025 | ₹3,178.00 |
Aster DM Healthcare Share Price Target 2045
By 2045, Aster DM Healthcare share price target can range from a minimum of ₹3,864 to a maximum of ₹4,263. The company has received a crucial approval from India’s Competition Commission (CCI). Now, Aster DM and Blackstone-backed Quality Care India Ltd will work together. After the merger, a new company will be formed, which will be counted among India’s top 3 hospital chains.
| Month | Aster DM Target Price 2045 |
|---|---|
| January 2025 | ₹3,864.00 |
| February 2025 | ₹3,899.36 |
| March 2025 | ₹3,934.73 |
| April 2025 | ₹3,970.09 |
| May 2025 | ₹4,005.45 |
| June 2025 | ₹4,040.82 |
| July 2025 | ₹4,076.18 |
| August 2025 | ₹4,111.55 |
| September 2025 | ₹4,146.91 |
| October 2025 | ₹4,182.27 |
| November 2025 | ₹4,217.64 |
| December 2025 | ₹4,263.00 |
Aster DM Healthcare Share Price Target 2050
By 2050, Aster DM Healthcare share price target is predicted to range from a minimum of ₹5,326 to a maximum of ₹6,242. The company is actively operating not only in India but also in international markets like UAE, Saudi Arabia, Oman, Qatar, and other countries. This global presence provides strong support to its business.
| Month | Aster DM Target Price 2050 |
|---|---|
| January 2025 | ₹5,326.00 |
| February 2025 | ₹5,410.27 |
| March 2025 | ₹5,494.55 |
| April 2025 | ₹5,578.82 |
| May 2025 | ₹5,663.09 |
| June 2025 | ₹5,747.36 |
| July 2025 | ₹5,831.64 |
| August 2025 | ₹5,915.91 |
| September 2025 | ₹6,000.18 |
| October 2025 | ₹6,084.45 |
| November 2025 | ₹6,168.73 |
| December 2025 | ₹6,242.00 |
Aster DM Healthcare Share Price Target 2025-2050
| Year | Aster DM Healthcare Target Price |
|---|---|
| 2025 | ₹385 – ₹572 |
| 2026 | ₹491 – ₹683 |
| 2027 | ₹536 – ₹741 |
| 2028 | ₹627 – ₹843 |
| 2029 | ₹712 – ₹934 |
| 2030 | ₹883 – ₹1,083 |
| 2035 | ₹1,642 – ₹1,983 |
| 2040 | ₹2,717 – ₹3,178 |
| 2045 | ₹3,864 – ₹4,263 |
| 2050 | ₹5,326 – ₹6,242 |
Read Also: Amara Raja Batteries Share Price Target 2025, 2026, 2030, 2040 to 2050
Aster DM Healthcare Technical Analysis
Aster DM Shareholding Pattern
In Aster DM Healthcare’s shareholding pattern, promoters have consistently increased their stake, showing strong confidence in the company. FIIs had significantly raised their holding in March 2023, but since then, they have gradually decreased their stake.
Interestingly, as FIIs reduced their holding, DIIs stepped in and increased their stake. Also, public holding has seen a sharp decline — from 52.20% in March 2018 to just 11.60% by March 2025, indicating strong institutional accumulation.
Overall, Aster DM Healthcare’s shareholding pattern looks quite strong, with rising promoter holding and solid interest from both FIIs and DIIs, which reflects long-term confidence in the company’s fundamentals.
| Date | Promoters | FIIs | DIIs | Public | Others |
|---|---|---|---|---|---|
| Mar 2018 | 37.46% | 6.84% | 2.77% | 52.20% | 0.73% |
| Mar 2019 | 37.80% | 7.45% | 2.29% | 51.86% | 0.59% |
| Mar 2020 | 37.87% | 10.81% | 6.51% | 44.23% | 0.58% |
| Mar 2021 | 37.88% | 10.57% | 8.72% | 42.33% | 0.50% |
| Mar 2022 | 37.88% | 11.03% | 8.64% | 41.99% | 0.46% |
| Mar 2023 | 41.88% | 38.63% | 8.93% | 10.12% | 0.43% |
| Mar 2024 | 41.88% | 33.48% | 13.70% | 10.59% | 0.35% |
| Mar 2025 | 41.89% | 21.66% | 24.59% | 11.60% | 0.26% |
Aster DM Healthcare Bullish & Bearish Cases
Bullish Cases (Good Points)
- A big part of Aster DM Healthcare’s income comes from GCC countries (like UAE, Saudi Arabia), where people have more money and hospitals are growing fast.
- In India, the company is using an “asset-light” model, which means they spend less money but can still earn good profits.
- Older people, lifestyle-related diseases, and medical tourism are increasing — this helps the healthcare business grow.
- Aster is also offering digital health services like “Aster@Home” and video consultations, which makes the company ready for the future.
- The company sold a large part of its Gulf business, so now it has less debt and can focus more on its Indian operations.
Bearish Cases (Bad Points)
- There might be delays and problems while expanding in India — like rules, approvals, or hiring skilled staff.
- The Indian healthcare sector is very competitive with big players like Apollo, Fortis, Narayana, and Medanta.
- Healthcare is a tightly controlled sector. Government rules on drug prices or treatment costs can reduce company profits.
- After selling part of the Gulf business, managing both India and Gulf operations smoothly could be a challenge.
- If foreign currency rates (like USD) change a lot, it can affect the company’s profits and expenses.
Final Thoughts on Aster DM Healthcare Share Price Target
Currently, there is significant competition in India’s healthcare sector, but at the same time, the demand for healthcare is rapidly increasing, which is expected to benefit healthcare companies.
After considering various factors, including technical analysis and other metrics, the Aster DM Healthcare share price target has been predicted. This prediction takes into account the company’s strong positioning in the market and the growing healthcare demand in India.
Disclaimer: We are not SEBI-registered advisors. The information on this website is only for learning and should not be taken as financial or investment advice. The stock market has risks, so always do your own research or talk to a financial expert before investing. All Target Price and its team are not responsible for any loss caused by the information on this website.
FAQs:
Is ASTERDM a good company?
Yes, Aster DM Healthcare could be a good company as it is a multinational healthcare firm, and a majority of its revenue comes from the GCC countries. Although the fundamentals are natural, the growth in the stock has been quite strong, indicating a positive outlook for the company’s future performance.
What is the price target for ASTERDM in 2025?
According to our latest forecast, in 2025, Aster DM Healthcare’s target price could range from a minimum of ₹385 to a maximum of ₹572. This prediction is based on various market factors and the company’s performance outlook.
What is the future of Aster DM Healthcare?
Aster DM Healthcare’s future looks quite promising, as the company has developed an expansion plan. By FY27, it aims to add over 1,700 new beds, bringing the total to more than 6,500 beds.
Is Aster DM Healthcare a good buy for long term?
Yes, Aster DM Healthcare could be a good option for the long term, as the company’s promoter, FII, and DII holdings are quite strong. However, it is crucial to conduct thorough research before making any investment decisions to understand the company’s fundamentals and market trends fully.
Is Aster DM stock overvalued or undervalued?
Yes, Aster DM Healthcare stock appears to be overvalued, as it is currently nearing its 52-week high. This typically indicates that the stock may be trading at a premium, and could be overpriced relative to its intrinsic value.
Hi, my name is Harsh Yadav, and I welcome you to All Target Price (alltargetprice.com). On this website, research and analysis-based share price targets are created, meaning they are predicted, and we have 7 years of experience in the share market.
